InterMune, Inc. (NASDAQ:ITMN)
CAPS Rating:
The Company is a biotech company focused on developing and commercializing innovative therapies in pulmonology and hepatology.
Growing the love for investing
The Company is a biotech company focused on developing and commercializing innovative therapies in pulmonology and hepatology.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
bull